Hjem › Blodkreft › District of Columbia › Washington
Kliniske studier for Blodkreft i Washington, DC
19 studier for Blodkreft søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi unna
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi unna
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mi unna
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Longitudinal Studies of Patient With FPDMM
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
RekruttererObservasjonsstudie
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi unna
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
RekruttererFase 1
- Childrens National Medical Center, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
Rekrutterer
- Georgetown University School of Medicine, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7 mi unna
- Nih/Nhlbi, Bethesda · 7 mi unna
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RekruttererFase 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi unna
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RekruttererObservasjonsstudie
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 7 mi unna
Blodkreft-studier i andre byer
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Seattle, WA18 studier
- Baltimore, MD18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Chicago, IL15 studier
- Philadelphia, PA14 studier
- Columbus, OH13 studier
- Edison, NJ13 studier
- Nashville, TN13 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.